Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 240
- Locations
- 1
- Primary Endpoint
- Symptoms
Study Overview
Brief Summary
The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with chronic obstructive pulmonary disease.
Detailed Description
This study is a randomized clinical trial for patients with chronic obstructive pulmonary disease from a primary care. The purpose is to determine the effectiveness of telemedicine (teleconsultation and telemonitoring) in control of chronic obstructive pulmonary disease symptoms.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Investigator)
Eligibility Criteria
- Ages
- 12 Years to 100 Years (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •spirometry from TelessaudeRS-Universidade Federal do Rio Grande do Sul (from randomization cluster), Modified Medical Research Council Dyspnea > 0
Exclusion Criteria
- •normal or restrictive spirometry, low quality spirometries (inadequate)
Arms & Interventions
Control
Spirometry in baseline Spirometry - 20 weeks
Intervention: Spirometry (Other)
Control
Spirometry in baseline Spirometry - 20 weeks
Intervention: Spirometry - 20 weeks (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
Intervention: Spirometry (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
Intervention: telemonitoring (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
Intervention: teleconsultation (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
Intervention: Spirometry - 20 weeks (Other)
Outcomes
Primary Outcomes
Symptoms
Time Frame: 20 a 22 weeks
Modified Medical Research Council Dyspnea Scale (difference in mMRC)
Secondary Outcomes
- Spirometry - FEV1(20 a 22 weeks)
- Spirometry - FVC(20 a 22 weeks)